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Abstract
There is increasing evidence for a connection between DNA replication and the expression of adjacent genes. Therefore, this
study addressed the question of whether a herpesvirus origin of replication can be used to activate or increase the
expression of adjacent genes. Cell lines carrying an episomal vector, in which reporter genes are linked to the murine
cytomegalovirus (MCMV) origin of lytic replication (oriLyt), were constructed. Reporter gene expression was silenced by a
histone-deacetylase-dependent mechanism, but was resolved upon lytic infection with MCMV. Replication of the episome
was observed subsequent to infection, leading to the induction of gene expression by more than 1000-fold. oriLyt-based
regulation thus provided a unique opportunity for virus-induced conditional gene expression without the need for an
additional induction mechanism. This principle was exploited to show effective late trans-complementation of the toxic viral
protein M50 and the glycoprotein gO of MCMV. Moreover, the application of this principle for intracellular immunization
against herpesvirus infection was demonstrated. The results of the present study show that viral infection specifically
activated the expression of a dominant-negative transgene, which inhibited viral growth. This conditional system was
operative in explant cultures of transgenic mice, but not in vivo. Several applications are discussed.
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Introduction
Herpesviruses are among the most complex DNA viruses,
encoding up to 200 genes. The characteristic temporal control of
viral gene expression ensures the appropriate regulation of the
morphogenic process. Transcription factors, activated immediate-
ly upon virion entry into cells or after reactivation of latent viruses,
regulate the expression of early genes and start a cascade of
transcription of early-late, leaky-late and true-late genes [1].
Remarkably, in contrast to leaky-late genes, expression of true-late
genes begins only after viral DNA replication, and can be blocked
by inhibitors of the viral DNA polymerase such as phosphonoa-
cetic acid (PAA) [2]. As the expression of true-late genes depends
upon viral replication, the promoters of late genes were analyzed
in the context of origin of lytic replication (oriLyt) sequences.
Notably, isolated true-late promoters encoded by plasmids or
integrated into the cellular genome respond like early promoters
upon infection. Yet, the same promoters, together with an oriLyt
provided in cis, restore the typical late expression patterns. This
property was first demonstrated for HSV-1 [3], but was confirmed
for several other herpesviruses [4,5]. Six conserved replication
proteins comprise the core components of lytic DNA replication
and are shared by all herpesviruses [6]. To a certain degree, the
core replication machinery can be complemented by another
herpesvirus [7]. Yet, closely-related cytomegaloviruses (CMV)
oriLyts are not exchangeable; the human CMV oriLyt cannot be
activated by murine CMV or simian CMV [8,9].
Two models have been proposed to explain the mechanism of
lytic DNA replication. One includes circularization of the parental
linear viral genome in the nucleus followed by an initial
bidirectional theta-replication followed by a rolling circle mech-
anism [10]. An alternative model suggests a biphasic process in
which DNA replication is initially induced by an origin-binding
protein, which then recruits the replication machinery to the
oriLyt sequences [11]. Later, it switches to a recombination-
dependent replication and/or rolling circle mechanism [12], in
which D-loop formation contributes to replication initiation [13].
This model is reflected by the highly branched concatemeric
genomes observed in herpesvirus DNA replication.
Lytic replication origins have been identified by transient
plasmid replication assays [6]. In these studies, cells transfected
with plasmids containing putative oriLyt sequences were infected
with the respective viruses. Under these transient conditions,
plasmids containing an oriLyt were replicated by the viral
machinery provided in trans. Stable maintenance of oriLyt-
containing plasmids has been described for herpesvirus amplicon
vectors. Herpes viral amplicon vectors contain an oriLyt, a gene
(or genes) and, importantly, packaging signals for vector DNA
incorporation into herpesvirus virions [14]. Standard amplicon
vectors are diluted in dividing cells, yet hybrid vectors containing
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attachment region (S/MAR) sequences enhance stability. While
expression of transgenes delivered to target cells has been analyzed
in several studies, the potential impact of the presence of the oriLyt
on transgene expression has not been addressed.
Conditional gene expression systems are important tools in
virology and help to avoid toxicity and related problems. Inducible
systems are usually based on additional elements that provide
regulatory factors such as the Tet-system, or on recombination-
dependent gene expression, such as the Cre/loxP mediated
system. It is important to note that many viral promoters can
also be trans-activated upon virus infection; however, their
induction usually follows early or early-late kinetics and ranges
only in the linear scale [15] and, thus, compares poorly with the
viral expression levels and kinetics shown by late genes. Therefore,
the aim of the present study was to construct an inducible
expression system, which is stably maintained in the host cell and
allows strong induction of late genes.
Although replication of a DNA fragment containing a lytic
origin of HSV-1 (oriS) was initiated by superinfection [16], other
studies show contradictory results [17], suggesting effects due to
the host chromatin environment. To avoid this, we used the pEPI-
1 vector as a backbone. The pEPI vectors are non-viral episomes
that are maintained by an S/MAR element and replicate semi-
conservatively once per cell cycle. These vectors can be
maintained in many cell types without selection [18,19]. Also,
maintenance of the episome in mouse cell lines did not prevent
silencing of the encoded transgene [20].
Here, we show that transcription units that are combined with
an MCMV-oriLyt encoded on the pEPI background are indeed
silenced. Yet, specific induction of DNA replication and gene
expression both occurred after viral infection. Most notably, this
system proved to be very useful for protein trans-complementation
of defective viruses and studies of dominant-negative (DN) viral
function.
Results
Mechanism of replication-dependent gene induction
A recurrent problem in transgenesis is the phenomenon of gene
silencing [21]. Yet, gene silencing might be advantageous if
constitutive gene expression is not favored. To obtain a gene
expression system that is induced by infection by specific viruses,
we relied on the fact that herpesviruses activate gene expression in
trans, interfere with the host silencing machinery [22,23], and will
replicate constructs containing an oriLyt [9,24]. Therefore, we
established a novel CMV-inducible gene expression system in
which natural silencing of the gene of interest in the transgenic cell
is obtained. DNA replication after CMV infection then liberates
the transgene, leading to the powerful induction of expression
(Supp. Fig. S1C).
Construction of the replicon vector pEpibo-luc-ori
MCMV was chosen because it is well characterized and
facilitates in vivo investigation. Furthermore, the position of the
minimal oriLyt of MCMV has already been defined [9]. It is
located within a complex and highly structured locus containing
several palindromes, inverted and direct repeats, and transcription
factor binding sites. It has been shown for other herpesviruses that
additional sequences flanking the minimal oriLyt can enhance
replication; therefore, we decided to clone a 3.9-kb fragment
containing the minimal 1.7-kb oriLyt fragment and adjacent
sequences. Due to its size and the presence of various repeats,
PCR amplification of the template was not feasible. So, we cloned
the oriLyt fragment using a new BAC-based pick-up strategy
(Supp. Fig. S1A) and inserted it into the episomal vector, pEpibo.
To test the replicon vector, we used firefly luciferase (FL) as a
reporter and measured the induction of gene expression in
response to oriLyt activation by creating the vector, pEpibo-luc-ori
(Supp. Fig. S1B). Here, FL expression was driven by the minimal
SV40 promoter, which is not induced upon infection with MCMV
(Supp. Fig. S2).
Reporter gene expression from the oriLyt-replicon is
inactivated by histone-deacetylase-dependent silencing
and is resolved by MCMV infection
To characterize the gene expression driven by pEpibo-luc-ori,
two independent pools of NIH3T3 transfectants were generated.
In the absence of infection, FL expression decreased to the limit of
detection after 16 weeks in both pools (luc-ori-t1 and -t2).
However, infection with MCMV restored FL expression by 3 to
4 orders of magnitude in both transgenic cell pools, irrespectively
of the treatment time (Fig. 1A). Thus, loss of FL expression due to
silencing was recovered upon virus infection.
There are several different mechanisms of transgene silencing
[21]. We wanted to determine whether the construct was
inactivated by de novo methylation of the promoter sequences, or
whether chromatin condensation was the main contributor. We
added specific inhibitors to cell clones derived from the cell pool,
luc-ori t1, and measured FL expression after 36 h. Three sub-
clones (cl.1, cl.2, cl.3) showed a basal level of FL expression and
one clone was negative (cl.4) before treatment. Inhibition of CpG-
methylation by 25 mM5 9-aza-cytidine [21] did not enhance
expression, but treatment with 330 nM trichostatin A (TSA)
resulted in about 100-fold induction in cl.1, cl.2 and cl.3 (Fig. 1B)
. Efficiency of 59 aza-cytidine treatment was controlled by recovery
of methylation-dependent de-silencing of GFP fluorescence (Supp.
Fig S3A). Recovery of FL induction by TSA was dose-dependent,
but achieved induction levels lower than those obtained by
infection with MCMV (Supp. Fig S3B). Furthermore, we found
only limited co-operativity of TSA and MCMV infection on the
induction of FL expression (Supp. Fig S4B). Western Blot analysis
of MCMV infected cells treated with TSA revealed an enhance-
ment of immediate early gene expression as previously described
Author Summary
All herpesviruses show a precisely regulated gene expres-
sion profile, including true-late genes, which are turned on
only after the onset of DNA replication. We used this
intrinsic viral mechanism to generate a versatile condi-
tional gene expression system that exploits the activity of
the murine cytomegalovirus (MCMV) viral origin of lytic
replication (oriLyt). Upon virus infection, replication of the
viral genome also led to the replication and activation of
the oriLyt-coupled episomal transgene. The oriLyt-based
replicons were silenced in all stable cell lines and
transgenic mice; however, virus infection liberated the
plasmids from histone-deacetylase-induced inactivation.
As maximum gene expression relied on relief from
silencing via replication of the episomal constructs, very
strong induction of the reporter gene was achieved. We
showed that this system can be used for trans-comple-
mentation of late, toxic viral genes, to block virus
production by activating dominant-negative (DN) trans-
genes, and to provide a new tool to study the principles of
viral replication.
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S4A). Accordingly, 330 nM TSA inhibited MCMV production by
100-fold in a multi-step growth curve analysis (Supp. Fig S4B). Thus,
MCMV infection could enhance FL signals induced by TSA, but was
inhibited itself with increasing TSA concentrations. Consequently, the
highest FL induction was achieved in infected cells without TSA
treatment (Supp. Fig S4C). Interestingly, FL expression by clone cl.4
was not detectable under any conditions; this may have been due to the
lack of an intact pEpibo-luc-ori episome or integration. As TSA is a
potent inhibitor of histone deacetylases (HDACs) [26], these results
strongly suggest that pEpibo-luc-ori driven gene expression is
constrained by histone modifications other than DNA methylation.
Activation of the replicon is specific to infection with the
respective virus
We then asked whether virus specificity, namely infection with
MCMV, is necessary to activate FL from the replicon vector. As
the core replication machinery is conserved in herpesviruses, we
determined whether a herpesvirus from another subfamily could
induce gene expression by the MCMV oriLyt system. As NIH3T3
cells are also permissive for the MHV68 c-herpesvirus, which
induces lytic replication in almost all infected mouse cells, we
examined infection of an isolated cell clone, luc-ori cl.1, with
MHV68 and MCMV (Fig. 2A). Whereas infection with MCMV
resulted in typically high induction of FL expression (by three
Figure 1. Infection with MCMV reactivates silenced replicon vector encoded reporter gene expression. (A) In two stable NIH3T3 cell
pools transfected with pEpibo-luc-ori (luc-ori t1, luc-ori t2) expression of FL was measured in absence of infection (plain bars, - MCMV) at the
indicated weeks after transfection. Reporter gene expression is lost in uninfected cells over time. At the same time points the pools were infected
with MCMV at an MOI of 0.5 (hatched bars, +MCMV). 24 h p.i. of both luc-ori t1 and t2 with high expression of FL was induced. NIH3T3 fibroblasts
served as a control to determine background signal (BG) of the luciferin substrate. (B) Vector pEpibo-luc-ori was inactivated by histone deacetylation.
Four cell clones (cl. 1–4) derived from subcloning of luc-ori t1 were subjected to treatment with 25 mM5 9 aza-cytidine (59Aza, gray bars), an inhibitor
of CpG-methylation, 330 nM Trichostatin A (TSA, black bars) for 36 h or left untreated (mock, open bars). FL expression was analyzed in comparison
to parental NIH3T3 cells. FL expression was significantly enhanced by de-condensing histone packaging through TSA treatment (*** p,0.001, ns
p.0.05, Two-Way-Anova, depicted is mean+SD). RLU (relative light units), p.i. post infection, weeks=weeks post transfection of pEpibo-luc-ori.
doi:10.1371/journal.ppat.1002728.g001
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marginal increase of (,5–10-fold). Because only MCMV was able
to fully activate expression of the MCMV-oriLyt-replicon, the
induction of the replicon system appears to be specific for infection
with the corresponding herpesvirus.
Induction of luciferase expression and de-silencing of
pEpibo-luc-ori requires viral DNA replication
In view of the fact that silencing of pEpibo-luc-ori was lifted
upon MCMV infection, we analyzed the role of the oriLyt
element. To this end we constructed pEpibo-luc, which lacks the
Figure 2. Induction of replicon vector is dependent on the MCMV DNA replication. (A) Induction of MCMV oriLyt is specific to MCMV
infection. Cell line luc-ori cl.1 was infected with MCMV (beta herpesvirus; MOI=0.5) or murine herpesvirus 68 (MHV68, gamma herpesvirus; MOI=0.5)
or left untreated. 36 h p.i. a bioluminescence assay was performed and the induction of the FL was calculated as the ratio of RLU of infected to
uninfected cells. (B) NIH3T3 cells were stably transfected with pEpibo-luc (luc t1) or pEpibo-luc-ori (luc-ori t3). Depicted is the ratio of FL expression of
the resulting cell pools before and after infection with MCMV at an MOI of 1. In the luc t1 cell pool, lacking the oriLyt sequence, FL expression is not
enhanced by infection, in contrast to the luc-ori t3 cell pool, in which FL expression is induced about 40 fold at 36 h p.i. (C) NIH3T3 or luc-ori cell lines
(luc-ori cl.1–cl.4) were infected with MCMV at an MOI of 0.5 (hatched bars) or left uninfected (plain bars). In addition, cell lines were either treated with
phosponoacidic acid (PAA, 300 mg/ml, black bars) or left untreated (white bars). 36 h p.i. FL induction was measured via bioluminescence assay. While
reporter expression is induced up to 1000-fold in MCMV infected cells lines cl.1–3, inhibition of viral DNA polymerase by PAA blocks the induction of
FL expression. (D) Induction can be inhibited with PAA completely if it is added before replication has started and can be reduced if added after the
onset of DNA replication. Cell line luc-ori cl.1 was infected with MCMV at an MOI=0.5 or left uninfected. Arrows indicate time points when 300 mg/ml
PAA was added to the cells. Cells were harvested at indicated time points and FL was measured via bioluminescence assay. Induction of the FL was
calculated as the ratio of RLU of infected to uninfected cells. (p.i., post infection; BG=Background; ***: p,0.001, ns: p.0.05, Two-Way-ANOVA,
depicted is mean+SD).
doi:10.1371/journal.ppat.1002728.g002
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NIH3T3 cells transfected with the pEpibo-luc generated cell pool,
luc t1, and NIH3t3 cells transfected with pEpibo-luc-ori generated
cellpool, luc-ori t3(Fig.2B). Silencingofconstitutive FLexpression
was observed in both cell lines over time (data not shown). Yet,
infection with MCMV enhanced the reporter signal selectively in
the oriLyt-containing cell line, luc-ori t3, but not in the oriLyt
negative cell line, luc-t1. It is important to note that oriLyt is located
downstream of the multiple cloning sites into which the transgene/
FL was inserted; thus, transgene transcription cannot be activated
by means of cryptic promoter regions. This confirms the key role
played by the oriLyt element in MCMV infection-dependent
activation of FL expression in the luc-ori cell lines.
Next, we examined whether induction of the luc gene in pEpibo-
luc-ori requires DNA replication of the infecting MCMV. Cell
clones, luc-ori cl.1–cl.4 were infected with MCMV in the presence
or absence of PAA, a specific inhibitor of the viral polymerase
[27]. In the absence of PAA, FL expression in cell clones luc-ori
cl.1–cl.3 increased by 100–1000-fold upon infection with MCMV
(Fig. 2C). However, in presence of PAA, FL expression was
similar to that in uninfected cells. PAA alone, in absence of
infection, had no influence on FL expression. These data clearly
show that induction of pEpibo-luc-ori expression upon MCMV
infection was inhibited by PAA. Thus, MCMV-induced de-
silencing and induction of FL was dependent on viral DNA
replication. Cell line luc-ori cl. 4 did not respond to any treatment
as already seen in the TSA experiments. Induction of FL in the
controls began at the onset of DNA replication and increased
exponentially over time (Fig. 2D; dark hatched columns).
Notably, PAA was only able to inhibit induction of the oriLyt
system when added prior to the onset of DNA replication, which
starts around 8–12 h p.i. in MCMV [28,29](Fig. 2D). If PAA was
added after the initiation of replication, its effect on FL expression
levels waned, further supporting the contribution of viral DNA
replication. FL induction after infection proved to be a very robust
property of the cell lines, as the level of induction was maintained
in luc-ori cl.1 cells even after more than 6 months of continuous
culture (data not shown).
Because induction of reporter gene expression from the vector
was dependent on the oriLyt sequence (Fig. 2B), quantitative
PCR (qPCR) experiments were performed to determine whether
the episomal vector was amplified during infection. We measured
the relative pEpibo-luc-ori copy numbers in infected and
uninfected cells normalized to the endogenous murine lbr gene.
Induction of FL expression (Fig. 3A) correlated with a significant
increase in the pEpibo-luc-ori copy number (about 50-fold;
Fig. 3B). Notably, in the cell line, luc-ori cl.4, in which MCMV
infection did not de-silence FL expression, there was no increase in
the copy number of the replicon vector sequence (Supp Fig. S5).
Phosphonoformic acid (PF), like PAA, is a specific inhibitor of
herpesvirus DNA polymerases. As expected, no amplification of
the vector was detected after PAA or PF treatment of infected luc-
ori cl.1 cells (Fig. 3B), whereas infection of luc-ori cl.1 cells in the
absence of inhibitors resulted in a ,2500-fold increase in FL
induction and a ,50-fold increase in replicon vector amplification.
By contrast, liberation of the vector from silencing by treatment
with 300 nM TSA, without additional vector replication, resulted
in only a moderate ,25–30 fold induction of FL in luc-ori cl.1
cells (Fig. 3A, B).
OriLyt-inducible activation of gene expression trans-
complements late viral proteins
Trans-complementation of late gene defects by cell lines
constitutively expressing the gene of interest is sometimes
challenging. Incorrect timing, insufficient expression levels, aber-
rant intracellular distribution of isolated proteins, or toxicity of the
constitutively expressed viral transgenes, can complicate cell based
trans-complementation systems [30–32]. In particular, high
constitutive expression of viral glycoproteins is often toxic to cells
[33,34]. As the replicon vector was maintained with low basal, or
Figure 3. pEpibo-luc-ori is amplified upon MCMV infection. luc-ori cl.1 cells were infected with MCMV (white hatched bars), MHV68 (black
hatched bars) at an MOI of 1 or left untreated (white bar, mock), or treated with 330 nM TSA. In addition, the DNA replication inhibitors PAA (300 mg/
ml) and PF (100 mg/ml) were added to infected cells. (A) Bioluminescence assay was performed to determine the FL induction and (B) quantitative
realtime PCR was performed 36 h p.i. to determine copy numbers of pEpibo-luc-ori vectors by a PCR specific for the bsr coding sequence compared
to the cellular gene lamin B receptor (lbr).
doi:10.1371/journal.ppat.1002728.g003
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that this system may be suitable for trans-complementation of late
gene defects. To examine this, we constructed two cell lines, one
encoding a glycoprotein (gO) and the other encoding the protein
M50, which is known to be toxic after isolated expression [30].
This protein performs an essential function during export of the
nascent viral capsid from the nucleus to the cytoplasm.
We cloned the m74 gene, coding gO [35], into the oriLyt vector
to generate the responding cell line NIH3T3:gO-ori (gO-ori).
MCMV, like HCMV, lacking gO is restricted to focal spreading
and the release of infectious virions into the supernatant is
hampered [35]. In the cell line containing the gO-ori vector,
however, infection with MCMV-DgO should lead to pEpibo-gO-
ori replication and m74 gene expression; thereby reconstituting
release of infectious progeny. MCMV-DgO released from
NIH3T3 about ,2–2.5 orders of magnitude less virus than
MCMV-wt. By contrast, growth in the complementing cell line
resulted in comparable titers for both MCMV-DgO and MCMV-
wt (Fig. 4A). Thus, the virus defect was rescued and the virus was
no longer restricted to a focal growth pattern (Fig. 4B). This
confirms that the replicon expression system can be used to
efficiently produce late viral proteins in trans. To determine
whether the viral genome reverts to a wt-like virus due to
recombination with the episomal replicon vector, PCR analysis of
the m74 gene (gO) was performed using viruses harvested on day 5
from the supernatants used in the growth curve experiments.
Supernatants were centrifuged to remove cells and the cellular
DNA was digested with DNase to discriminate between the m74
gene in the replicon vectors in the cells and the viral genome. The
fact that the supernatants were free from cellular debris was
confirmed by the lack of the cellular gene lbr. Presence of viral
genomic DNA was confirmed by amplifying the viral DNA
polymerase, M54. Whereas all supernatants were positive for the
M54 gene and negative for the lbr gene, m74 was detected only in
MCMV-wt, and not in MCMVDgO, regardless of whether it
originated from NIH3T3 or gO-ori cells (Fig. 4C). Furthermore,
we never observed any reversion of the phenotypic restriction of
MCMVDgO to cell-to-cell spreading (data not shown). No
recombination was detected between the replicon vector and the
MCMVDgO virus.
To assess the suitability of the system for complementing a toxic
protein, the M50 gene (including a C-terminal HA-tag) was cloned
into the oriLyt vector to generate the cell line, NIH3T3:M50-ori
(M50-ori). Previous attempts at generating trans-complementing
M50 cell lines using conventional methods failed due to the
toxicity of the M50 protein [30]. To assess M50HA expression in
two M50-ori cell pools (M50-ori t1 and t2), Western blot analysis
was performed using an HA- specific antibody. Protein loading
was controlled by actin detection, and infection was controlled by
detecting the viral immediate-early proteins, IE1/IE3. No
M50HA protein was detectable in uninfected cells; however,
infection of the cell pools resulted in de-silencing and strong
expression of M50HA (Fig. 4D). To analyze trans-complemen-
tation and recombination, virus reconstitution from MCMV-BAC
DNA lacking the essential M50 gene was performed. To this end,
M50-ori t1 and M50-ori t2, as well as NIH3T3 cells and MEF
cells, were transfected with the BAC pSM3fr-D1-16-DM50-F. This
BAC harbors the deletion of most of the M50 ORF, however due
to overlap with the M49 gene 75 aa of the C-terminus of M50 had
to be left intact and is homologous to the sequence in the replicon
vector. Plaque formation was detected 3 days post-transfection in
both M50-ori pools (data not shown), but not in NIH3T3 cells or
MEF cells. Full cell lysis occurred 5 days post-transfection in the
M50-ori cell pools, whereas no viral progeny were detected in the
cells lacking the vector. To assess the efficiency of the reconsti-
tution, serially diluted supernatants were used to infect the cloned
cell line M50-ori cl. 2.1, or NIH3T3 cells. Titration of the
supernatant on M50-ori cl.2.1 cells harboring the M50-ori vector
revealed high titers (,2610
7 PFU/ml) of the trans-complemented
MCMV-DM50-F/M50HA. The reconstituted virus caused plaque
formation and virus spread on M50-ori cl. 2.1 cells in a
concentration-dependent manner, whereas only the signal from
first-infected cells was seen in non-complementing NIH3T3 cells,
without spread or plaque formation (Fig. 4E). Thus, the replicon
vector allowed efficient trans-complementation of the toxic
essential late protein M50. This complementation occurred at
the protein level since the virus was unable to spread in non-
complementing cells. However, we found that infection with
MCMVDM50-F/M50HA at a very high MOI resulted in
formation of a few plaques, even in MEF cells, indicative of some
genetic reversion. In the M50-ori cell pools, we calculated the
reversion rate to be about 1 out of 10
4–10
5 PFU (data not shown).
A replicon encoded DN protein inhibits virus production
in trans
Next, we studied whether virus replication can be inhibited by a
DN transgene induced late in the viral cascade. Inhibition of viral
spread by the use of DN viral proteins, called intracellular
immunization, was proposed by Baltimore in 1988 [36] and was
inspired by the work of Friedman and colleagues [37]. They
provided the proof-of-principle experiment showing that a
truncated VP16 protein could reduce the replication of HSV-1
when stably expressed by the host cell line. Since then, toxicity
caused by DN transgenes has been a problem [37–40]. To test the
usefulness of our system for studying dominant-negative effects, we
cloned the DN gfpscp gene [41,42], which codes for a fusion
between GFP and the small capsid protein (SCP) of MCMV, into
the oriLyt vector. During infection of the NIH3T3:gfpscp-ori
(gfpscp-ori) cell line, MCMV should de-silence expression of the
inhibitory protein GFPSCP. Strong expression of GFPSCP
should, in turn, block the egress of viral capsids from the nucleus
(Fig. 5A).
To examine the inhibitory potential of the gfpscp-ori cell line,
we performed growth curve analysis of MCMV in the inhibitory
cell line and NIH3T3 cells. In contrast to DN expression in cis in
the viral genome (which was about 1 million-fold reduced) [42],
induced expression of the DN in trans resulted in inhibition of virus
production by about 2 orders of magnitude only (Fig. 5B). This
was also true for other cell lines such as M210-B4 (data not
shown). However, complete inhibition could not be achieved,
perhaps due to the fact that SCP represents the most abundant
protein in viral capsids and, therefore, it is unlikely to be out-
competed by the DN protein.
We then considered heterogenous de-silencing of the transgene
in individual cells, either along with the cell cycle status or due to
other reasons, which may result in cell subpopulations in which
DN expression is absent. To address this possibility, we tested
recombinant viruses derived from pSM3fr-D1-16-SCPiChe-FRT
(MCMV-cherry). Here, the expression of mCherry served as a late
infection marker as its expression starts concordant with that of the
SCP gene. We observed a striking and specific correlation between
infected cells and cells positive for GFPSCP fluorescence (Fig. 5C).
Therefore, limited amounts of the DN protein rather than
heterogeneous de-silencing and subsequent lack of the inhibitory
protein in individual cells, is probably the cause of the limited DN
effect.
To examine the transgene copy number prior to infection,
fluorescence in situ hybridization (FISH) was performed. pEPI-1-
Replication Regulated Gene Expression
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PLoS Pathogens | www.plospathogens.org 7 June 2012 | Volume 8 | Issue 6 | e1002728based cell lines carry between 2–10 episomes per cell. FISH
analysis of the gfpscp-ori cell line revealed approximately two
episomal copies per cell (Fig. 5D) Integration events, as described
for the original pEPI-EGFP [43] vector, were also detected. In 34
of the analyzed metaphase spreads, we identified 31 times
episomal state of the pEpibo-gfpscp-ori vector. Additional
integrated vectors were detected in five metaphase spreads.
However, we did not find metaphase spreads associated with
integrated vectors alone.
A virus inducible oriLyt-dependent luciferase mouse
(VIOLA)
As already observed for several attenuated MCMV-mutants,
the reduction in virus titer of 99% observed in tissue culture may
result in even stronger attenuation if the system is operative in vivo
[44]. To test the oriLyt system in vivo, we transferred the
conditional DN principle to the natural host of MCMV, the
mouse. To our knowledge, no transgenic mouse has been created
based on the pEPI-1 vector. Therefore, to assess episomal stability
and to test de-silencing in vivo, we generated transgenic mice
carrying the pEpibo-luc-ori construct. This should permit the
general concept to be studied in vivo (Fig. 6A). To this end, we
transfected murine embryonic stem cells (mES line E14) with
pEpibo-luc-ori and isolated eight cell clones. Note that mES cells
are non-permissive for MCMV infection. To identify cell clones
suitable for blastocyst injection, several cell populations were
differentiated for 3 weeks to enable productive MCMV infection
[45]. To study virus specific de-silencing in differentiated mES, the
bioluminescence signal was measured both prior to and after
MCMV infection. In three of the eight clones, no FL expression
was detected under any conditions (A10, B1, B9); three other
clones showed a weak increase in FL expression after infection
(A2, A6, B11) and two clones were induced 7- (A3) and 30-fold
(B8) (Fig. 6B).
The latter two clones (named line A and line B) were used for
blastocyst injection. This led to at least one chimera for each line,
which transmitted the luciferase gene to the next generation (lines
were named VIOLA: virus inducible oriLyt-dependent luciferase
animal). Basal FL expression and FL induction was assessed by
measuring bioluminescence in lung explant cultures. Although the
VIOLA-B line was positive for the luc gene, it did not express FL
under any conditions (data not shown). Lung explants from 2
nd
generation VIOLA-A animals expressed FL selectively after
MCMV infection, and this property was maintained in subsequent
generations (Fig. 6C). Induction of FL expression after MCMV
infection was detected in each organ, whereas basal FL expression
in uninfected cells was undetectable. FL induction was also
observed in ex vivo explant cultures of other organs such as bone
marrow, heart, muscle, fat, spleen, and salivary glands of 4
th
generation animals (Fig. 6D). It is important to note that FL
expression in these ex vivo cultures was merely a semi-quantitative
estimate, as the explant cultures represent a heterogeneous pool of
cells both permissive and non-permissive for MCMV infection.
Therefore, although virus load was calculated as MOI=0.5, viral
infection could not be normalized.
To test whether virus-induced gene expression also operates in
vivo, we infected VIOLA-A mice with 1610
6 PFU i.v. and
measured the light signals using non-invasive imaging of whole
animals over a period of 5 days. As a control, 129X1/SvJ mice
were infected with 1610
5 PFU i.v. MCMV-luc [46]. Surprisingly,
although the luc gene was activated in the explant cultures, no
bioluminescence signal was detectable in the VIOLA mice in vivo.
This should not be due to limited detection of the signal because
the FL signal generated by the virus was easily detectable after
infection with MCMV-luc at a 10-fold lower virus dose (Supp. Fig
S6A). Furthermore, titration of the virus in organs of the infected
VIOLA mice revealed a normal viral load. Therefore a failure to
detect the FL signal in vivo is not due to reduced infectibility of
VIOLA mice (Supp. Fig S6B). Southern blot hybridization of the
transgenic mouse genomic DNA confirmed the presence of
pEpibo-luc-ori; however, our data also showed that pEpibo-luc-
ori sequences were integrated into the mouse genome (Supp. Fig
S7). Integration of the replicon vector was also suggested by the
fact that the inheritance pattern followed classical Mendelian rules.
Thus, pEpibo-luc-ori was transferred to the transgenic mice, but
the episomal state was not faithfully maintained.
Discussion
In this study, a herpesvirus lytic origin of replication was
combined with the transcription unit from an episomal vector to
generate a novel inducible expression system, which is induced by
infection with wt virus. In this system, herein referred to as the
‘‘replicon vector’’, basal background gene expression was negligi-
ble as it was silenced by a histone deacetylase-dependent
mechanism. However, upon viral infection, de-silencing and
activation of the replicon vector led to a .1000-fold increase in
induced gene expression. Neither genetic manipulation of the viral
genome nor administration of any chemical compound was
necessary. This replicon vector system may resolve difficulties
encountered when trans-complementing late proteins (namely
glycoproteins and toxic proteins), as shown by the trans-
complementation of the viral glycoprotein O, and the toxic viral
protein M50. Also, its utility for inhibiting virus multiplication was
demonstrated, as shown by the use of DN proteins, such as
GFPSCP.
Figure 4. Replicon vector based trans-complementation. A–C trans-complementation of a glycoprotein. (A) Trans-complementation of the
late glycoprotein gO can be facilitated by oriLyt-induced gene expression. NIH3T3 (striped bars) or gO-ori (plain bars) cell lines have been infected
with MCMV-wt (white bars) or MCMVDgO (black bars) at an MOI=0.05 and centrifugal enhancement. At the indicated time points the number of the
infectious virus was quantified in the culture supernatants by standard plaque assay. (B) Immunofluorescence microscopy of infected NIH3T3 or gO-
ori cells performed 5 days post infection (MOI=0.05). Infected cells were stained with the anti-IE antibody CHROMA-101. While MCMVDgO is
restricted to focal cell-to-cell spread in NIH3T3 fibroblasts, it spreads like wild type in the trans-complementing cell line gO-ori. (C) PCR analysis of
virus progeny produced on gO-ori cell line. Viral DNA was isolated from supernatants of the viral growth curve of (A) from day 5, cleared from residual
cells, and analyzed by PCR. The virus polymerase gene, M54 served as a positive control for viral infection. The cellular gene lbr, served as a control for
the lack of residual genomic DNA. PCR on the m74 gene, encoding gO, showed the presence of the gene in MCMV-wt and the lack of it in MCMVDgO.
No uptake and recombination of gO after passage over gO-ori cells could be detected. D–E Trans-complementation of M50, a protein essential for
nuclear export of viral capsids. (D) Detection of the M50HA protein (,35 kDa) in cell lysates of NIH3T3, M50-ori t1 and M50-ori t2. The respective cell
lines were infected with MCMV-wt at an MOI of 1 and cell lysates harvested 36 h p.i. (E) Growth of MCMVDM50-cherry on complementing and non-
complementing cell line. Supernatant of the reconstitution of MCMVDM50-cherry on M50-ori cl.2.1 was serial diluted and used to infect NIH3T3 or
M50-ori cells. The trans-complemented virus MCMVDM50-cherry/M50HA could spread in M50-ori cells, but produced only primary infection in
NIH3T3.
doi:10.1371/journal.ppat.1002728.g004
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PLoS Pathogens | www.plospathogens.org 8 June 2012 | Volume 8 | Issue 6 | e1002728Figure 5. Induction of a dominant-negative protein by the replicon vector inhibits viral growth. (A) In the transgenic cell line NIH3T3:
gfpscp-ori (gfpscp-ori), infection with MCMV induces replication of the construct and thereby activates the production of the dominant-negative
protein GFPSCP (green symbols). This protein blocks egress from the nucleus and viral spread is inhibited. (B) NIH3T3 (white bars) and gfpscp-ori
(black bars) cell lines were infected with MCMV-wt at MOI of 0.1. At the indicated time points, infectious virus was quantified in the supernatants by
standard plaque assay. Due to the production of the inhibitory protein, the cell line gfpscp-ori releases 100–200 - fold fewer viruses into supernatants.
(C) NIH3T3 or gfpscp-ori cell lines were infected with MCMV-mCherry at an MOI of 0.1 and expression of GFPSCP and mCherry was assessed 5 days p.i.
by fluorescence microscopy. The mCherry protein is expressed with late kinetics and serves as an infection marker. Only in infected cells GFPSCP is
produced and localizes according to its typical pattern in nuclear speckles. Plaques on the gfpscp-ori cell line are reduced in size. (D) FISH of
metaphase spreads of uninfected gfpscp-ori cells (4n=76). Three different probes complementary to the gfpscp gene (green), bsr gene (pink) and
oriLyt (red) were used. Probes co-localized to DAPI stained extrachromosomal spots, indicating an episomal persistence of pEpibo-gfpscp-ori.
doi:10.1371/journal.ppat.1002728.g005
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of silenced transgenes as inhibition with PAA or PF abolished
reporter gene expression. The presence of oriLyt in the replicon
vector was, therefore, essential for induction of gene expression.
Based on these data, we assume that oriLyt-mediated vector
replication induced by MCMV is the key to gene expression. If
there is further need for a true-late viral protein for activation
(whose production would be also inhibited by PAA), it must also
act in the context of the oriLyt sequence.
Induction of the MCMV replicon vector requires specific
elements that are shared between the vector and the activating
virus, since infection with MHV68 did not induce transgene
expression. Although herpesviruses comprise a conserved core of
replication proteins that can be exchanged between subfamilies
[6], the activation or origin binding protein/s in b- and c-
herpesviruses is highly diverse between subfamilies and even
within subfamilies. Although the mechanism of replication
initiation by origin binding proteins has been extensively studied
Figure 6. OriLyt dependent transgene expression in vivo. Generation of virus inducible oriLyt dependent luciferase animal (VIOLA). (A) (1.)
mES cell clones were transfected with pEpibo-luc-ori and (2.) pre-selected for their induction capacity by MCMV infection in vitro. (3.) Mouse lines
were analyzed for expression of FL before and after infection in explant cultures of different organs. (B) mES cells were transfected with pEpibo-luc-ori
and 8 clones were isolated. A portion of the clones were partially differentiated for 3 weeks and then infected with MCMV at an MOI of 0.5 or left
untreated. 36 h p.i. a bioluminescence assay was performed and the induction of the FL was calculated as the ratio of RLU of infected to uninfected
cells. mES clones A3 and B8 were selected for generation of transgenic animals. (C) Explant cultures of lungs taken from mice of the Viola–A strain,
backcrossed one (2
nd generation) or two (3
rd generation) times to 129X1/SvJ, were produced and were infected with MCMV-wt with an MOI of 0.5
(hatched bars) or left untreated (white bars). 24 h p.i. FL expression was determined by measuring relative light units (RLU). As a control mice of the
background strain 129X1/SvJ (wt/wt) were used. (D) Explant cultures from bone marrow (BM), heart (He), muscle (Mu), fat (FA), spleen (Sp) and
salivary glands (Sg) were grown from a VIOLA-A mouse of the fourth generation. Cells were infected with MCMV-wt with MOI of 0.5 (hatched bars) or
left untreated (white bars). 24 h p.i. FL expression was determined by measuring relative light units (RLU). (p.i.=post infection ; BG=background of
luciferin).
doi:10.1371/journal.ppat.1002728.g006
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available for other herpesvirus subfamilies. Interestingly, in CMV
and c-herpesviruses, proteins that work as transcriptional activators,
such as UL84 for HCMV [47], Zta for EBV [48,49] and K8 and
Rta for KSHV [50], are also necessary for the initiation of viral
DNA replication. In these cases, sequences have been identified that
might act as promoters [51,52], and a number of transcription
factor binding sites were identified in several oriLyts [52–54]. In the
present study, we can only exclude the effect of an intrinsic oriLyt
promoter, as the reporter gene was placed upstream of the
replication origin. However, the contribution of an enhancer
function within the oriLyt sequence remains the subject of debate.
Since induction was strongly dependent on DNA replication,
enhancer activity alone cannot explain the results. Therefore, we
assume that oriLyt-induced gene expression is due to: (a)
conformational changes in DNA structure or histone packaging
making the promoter for the reporter transgene more accessible to
the transcription machinery, and/or (b) a marked increase in the
number of templates available for transcription.
At first glance, the presence of both a viral oriLyt and transgenes
appears similar to an amplicon vector construct, as the amplicon also
contains both elements and, in addit i o n ,ap a cs i g n a l .H o w e v e r ,t h e
oriLyt within amplicon vectors serves only to amplify the vector DNA for
efficient packaging of a high number of vector copies into helper virus
capsids via the pac signal [14]. Interestingly, the phenomenon of
transgene silencing of amplicon vectors by HDAC-dependent mecha-
nisms has also been described [55]. Whether or not the context of the
oriLyt itself affects the level of gene expression has, to our knowledge, not
been investigated. Neither has the question of oriLyt-specific de-silencing
of the vector by super-infection of cells carrying the vector been
addressed. Taking the results of our study into account, we expect that
expression of transgenes provided by amplicons derived from human
pathogens would be affected by natural super-infection. This prediction
is testable using gene therapy studies incorporating herpesvirus amplicon
vectors. The strength of this effect would probably depend on details
such as transcription orientation and distance from the oriLyt sequence.
The replicon vector system for inducible gene expression should
be applicable to all herpesvirus subfamilies. Moreover, most DNA
viruses regulate late gene expression upon DNA replication,
although it is achieved via different mechanisms. Such replicon
vector systems may be applicable for polyomaviruses [56] and
adenoviruses [57] with minor modifications. Notably, there are
suggestions of a connection between the origins of replication and
enhanced gene expression in higher eukaryotic genomes [58,59].
Trans-complementation of late proteins involved in herpesvirus
morphogenesis is still a difficult task. Incorrect timing, aberrant
intracellular distribution due to missing viral interaction partners
and incorrect expression levels of the viral protein may explain
poor complementation results. For instance, the isolated expres-
sion of late herpesvirus promoters without providing an oriLyt in
cis results in aberrant early expression of the transgene. Today,
systems for inducible gene expression typically require the use of
small chemical compounds such as tetracyclin or doxycyclin (as in
the case of Tet-on/Tet-off systems) [60] or rapamycin (for
FKBP12-based systems) [61]. In these systems, gene expression
is activated synchronously and irrespective of the state of virus
replication in all cells, whereas the oriLyt-based system uses viral
DNA replication as the signal for induction. The expression of the
gene increases in proportion with the amplification of the vector
DNA and reflects the natural expression kinetics of late
herpesvirus genes. As each cell is activated individually upon
infection, the appropriate and correct timing of expression of the
trans-complementing gene is determined by the infecting virus.
Trans-complementation carries the risk of recombination of genes
provided in trans with the respective defective viral genome. We did not
observe phenotypic or genotypic reversion of the DgO-phenotype. By
contrast, we observed viable viruses at low levels in the M50-ori cell
lines after reconstitution of a non-viable M50 deficient BAC. The high
selection pressure for the production of infectious progeny favors the
replication of M50 recombined viruses. In the replication competent
gO-ori system, recombination only results in virus release; a phenotype
with limited selective advantages. However, the rare reversion events
observed during M50 complementation did not result in detectable
reversion of the phenotype in first generation progeny (see Fig. 4E).
Future studies are needed to identify the conditions that increase or
decrease the risk of recombination using replicon vectors.
We also used the system for antiviral intracellular immuniza-
tion. Constitutive expression of DN viral proteins in earlier studies
[40] resulted in major defects in mice, such as substantial weight
loss, probably due to cross-reaction between the dominant-
negative viral transcription activators and cellular proteins,
thereby altering natural gene expression profiles [40]. The
expected advantage of replicon vectors lies in the fact that the
DN protein is silenced. Thus, adverse effects caused by constitutive
expression of toxic proteins are minimized. Our results show that
we have been able to demonstrate proof-of-principle. It is not
surprising that we could not achieve complete inhibition of viral
replication in cell culture. A simple explanation is that the high
abundance of wt SCP protein produced during infection (in terms
of copy number per capsid) [62] simply out-competed the DN
protein. One option may be to isolate clones containing high initial
copy numbers of the replicon vector, or to replace the DN with
that of a less abundant target protein such as M53 [63].
Episomal maintenance of pEPI has been shown in transgenic
pigs, in which the pEPI-1 vector was not inactivated [64]. The
present study reports, for the first time, the generation of
transgenic mice using the pEPI replicon vector system. Function-
ality was testable in differentiated mES cell clones prior to
generation of the transgenic lines. Starting from two responsive
cell clones, two lines of VIOLA mice were generated. However,
integration of the pEpibo-luc-ori vector was apparent in both
VIOLA lines; although we cannot exclude the possibility that
some episomal copies remained. Stabilization of the episomal
properties could perhaps be improved by using murine S/MAR
sequences instead of the human sequences used so far.
Remarkably, we found no evidence for gene induction in vivo,
although reactivation of the reporter by MCMV was possible in ex
vivo explant cultures. Controls indicated that the failure to detect
the luciferase signal in living mice was not due to insufficient
sensitivity. The failure of transgene induction in vivo perhaps
reflects the chromatin conditions surrounding the integrated
constructs. These conditions change under in vivo and in vitro
conditions. Major epigenetic changes happen during ex vivo tissue
culture [65], which might impinge on the strength of replicon
vector silencing. Perhaps only metastable silencing conditions are
lifted upon infection.
Virus induced replication and expression forms the basis of the
here described replicon expression system. This represents a tool
kit, which can be favorably utilized for studying herpesvirus DNA
replication, trans-complementation, gene therapy vector produc-
tion and genetic immunization in vivo.
Material and Methods
Ethics statement
All animal experiments were performed in strict accordance
with German animal protection law (TierSchG) and approved by
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under protocol number 55.2-1-54-2531-195-09. The mice were
housed and handled in an SPF condition in accordance with good
animal practice and all efforts were made to minimize suffering as
defined by Federation of European Laboratory Animal Science
Associations (FELASA) and the national animal welfare body
Gesellschaft fu ¨r Versuchstierkunde - Society for Laboratory
Animal Science (GV-SOLAS).
Plasmids
The oriLyt of MCMV [9] was subcloned from an MCMV-bacterial
artificial chromosome (BAC) using a pick-up-cloning strategy. A PCR
fragment was amplified using primers H59-MCMV-oriLyt-ori6kan-for
(59-GGCGGGAGCG ACGGGGGCGA GGCTGGAGAG ATC-
GTCGTCC GCCATGCTAG CACGCGTGCC AGTGTTACAA
CCAATTAACC-39)a n dH 3 9-MCMV-oriLyt-ori6kan-rev (59-GAAC-
GACCCC CGCTCCTGTA TAATTTCGAT GCCGGGGAGG
TCGCCACGCG TCTGAAGATC AGCAGTTCAA CCTGTT-39)
containing homologies at H59 to 91850–91894 bp and H39 homologies
at 91895–91939 bp of the MCMV-FRT BAC pSM3fr-FRT flanking a
kanamycin resistance gene (kanR) and the bacterial oriR6K [66]. This
PCR fragment was recombined by homologous recombination into
pSM3fr-FRT as previously described [67]. Due to the insertion of a new
NheI site (at the most upstream position in the inserted fragment) the
oriLyt-containing genome segment could be excised together with the
bacterial amplicon and the kanR marker by NheI digestion, as the next
NheI site in the genome (at 95767 bp) was sited downstream of the
oriLyt. The fragments generated by NheI digestion were recircularized by
DNA ligation and used to transform PIR1 E. coli (Invitrogen). In PIR1 E.
coli, only the oriR6K (and thereby the oriLyt-containing circularized NheI
fragment) was maintained after kanamycin selection. The oriLyt
fragment was subcloned from the resulting pO6kan-oriLyt plasmid by
subsequent digestion with MluI and ligated into the MluIs i t eo fa
modified pEPI-1 vector containing a blasticidin resistance gene (bsr)a n d
an mOrange fluorescent marker (instead of the neomycin resistance
marker and the gfp gene in the original vector) [68] to yield pEpibo-
oriLyt.
An additional FL reporter gene, driven by the minimal SV40
promoter (48–250 bp) was excised from the pGL3-control plasmid
(Promega, Acc# U47296) and inserted into the pEpibo-oriLyt
vector upstream of the oriLyt via the KpnI and XbaI restriction
sites. The control plasmid, pEpibo-luc, was constructed by
inserting the same fragment into the pEpibo vector (w/o oriLyt).
To construct the pEpibo-GFPSCP-ori plasmid, the luciferase ORF
was excised from pEpibo-luc-ori via the HindIII and XbaI sites and
replaced with a PCR fragment containing the GFP-SCP ORF
[41] flanked by the respective restriction sites. The vector pEpibo-
gO-ori was generated by blunt-end cloning of the gO-ORF from
pCR3-m74 [34] via Ecl126II into the HindIII and XbaI sites of
pEpibo-luc-ori. To generate the pEpiNo-M50HA-ori vector,
which contains a neomycin selection cassette instead of the
blasticidin resistance gene, M50HA from pOriR6K-zeo-ie-
M50HA [69] was cloned into the HindIII and XbaI sites of
pEpiNo-luc-ori.
Cells lines
Mouse embryonal fibroblasts (MEFs) and NIH3T3 cells (ATCC
CRL-1658) were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum
(FCS), 100 units/ml penicillin, and 100 units/ml streptomycin.
To generate stable cell lines, NIH3T3 cells were transfected in 6-
well plates with 2.5 mg of the pEpibo construct using the TransIT-
3T3 (Mirus) transfection reagent according to the manufacturer’s
protocol. Transfected cells were selected with 10 mg/ml blasticidin
S (BS, Invivogen) or with 200 mg/ml G418 (Invivogen; for M50-
ori) and were either studied as cell pools or as clones isolated by
limiting dilution.
Viruses, infections and growth analysis
The MCMV-wt and MHV68-wt viruses were derived from
BACs pSM3fr and Rc HV68A98.02, respectively [70,71].
Reconstitution of the viruses, preparation of virus stocks and
titrations were performed as described previously [72,41]. To
determine in vitro growth of MCMV in different cell lines, cells
were plated at the same density and infected at an MOI of 0.1
(unless otherwise indicated). After 1 h of virus infection, cells were
washed and fresh medium supplied. Supernatants of the infected
cells were taken at the indicated time points (in triplicate) and
titrated against MEFs using a standard plaque assay, or against the
respective replicon cell line according to TCID50. Growth curve
experiments were performed at least twice. MCMV-DgO virus
production and trans-complementation were performed as
described previously [34].
The M50-deficient virus was generated by modifying pSM3fr-
D1-16-FRT [73]. First, to monitor late gene expression by
MCMV, an expression marker was introduced into the 39 UTR
of the M48.2 gene, which encodes the small capsid protein (SCP).
The internal ribosome entry site (IRES) of the encephalomyocar-
ditis virus was derived from pIREShyg3 (Clontech, nt 1333–1924)
and assembled upstream to the mCherry ORF from pmCherry-
C1 (Clontech nt 597–1448). This IRES-mCherry cassette was then
introduced into MCMV-BAC between nt 73570 and nt 73571
and directly after the M48.2 stop codon by recombineering [74]
yielding pSM3fr-D1-16-FRT-SCPiChe. Next, the EGFP coding
region from pEGFP-N1 (Clontech nt 679–1398) and the
ampicillin resistance gene from LITMUS 28 (NEB nt 2764–
1003) were assembled and introduced into pSM3frD1-16-FRT-
SCPiChe between nt 75730–76451 via a second round of
recombineering to yield pSM3fr-D1-16-DM50F. The newly-
inserted cassette replaced most of the M50 ORF and allowed
the EGFP ORF to be expressed instead of the deleted M50. The
C-terminal 75 aa of M50, which overlap with the M49 gene, were
left intact as described for the M50 deletion mutants [75].
Generation of transgenic mice
To generate the VIOLA mouse line (virus inducible oriLyt-
dependent luciferase animal), the murine embryonic stem cell line,
mES E14, was transfected with pEpibo-luc-ori using an AMAXA
nucleofector (Lonza Cologne, Germany) according to the manu-
facturer’s instructions using program A-013. Transfected mES
cells were cultured in mES cell medium (DMEM containing 15%
FCS, 1% non-essential amino acids (Gibco) containing 1000 U/
ml LIF (Millipore, Temecula, USA)) on mitomycin C-treated
NIH3T3-bsr fibroblasts and selected with 5 mg/ml BS for 3 days.
To select the appropriate clones, a proportion of the mES cells was
differentiated by removing the LIF and feeder cells to allow
productive infection with MCMV [44]. Appropriate clones were
injected into C57BL/6 blastocysts, which were then implanted
into a NMRI foster mother. The resulting chimeras were
backcrossed to 129X1/SvJ mice (Jackson) to obtain the VIOLA
line.
Tissue explant cultures
For the explant cultures, the lungs, heart, muscle, fat and
salivary glands were excised from individual mice, washed with
PBS and minced in dissociation buffer (12.5 mM HEPES, 200 U/
ml DNaseI and 13 Wu ¨nsch U/ml Liberase TM in PBS). Tissues
were incubated at 37uC until a smooth homogenate was obtained.
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(prepared from the femurs) were passed through a 100-mm strainer
and resuspended in DMEM. Lung cells were resuspended in
LSGS medium (DMEM containing, 15% FCS, 1% non-essential
amino acids (NEAA), 1 mg/ml hydrocortisone, 10 ng/ml human
epidermal growth factor, 3 ng/ml basic fibroblast growth factor,
10 mg/ml heparin). Heart, muscle, salivary gland and fat cells were
cultured in DMEM containing 15% FCS, 1% NEAA and 50 mM
2-mercaptoethanol. Spleen cells were cultured in RPMI1640
containing 10% FCS, 1% L-glutamine and 10 mM HEPES. All
cells other than muscle were plated on gelatin-coated culture
flasks. Muscle cells were grown on collagen type V-coated culture
flasks.
Luciferase assays
To quantify FL expression, 100,000 cells/well were seeded into
12-well plates (in triplicate). After 4 h, the cells were either infected
with MCMV or mock-treated. At 24 or 36 h after infection, the
cells were carefully washed with PBS and lysed with 200 ml1 6
Passive Lysis Buffer (Promega). The luciferase activity in the lysates
(10 ml) was measured in a 96-well luminometer (Berthold).
Experiments were performed at least three times. For the analysis
of the silencing mechanism, cells were treated with 330 nM
trichostatin A (TSA), or 25 mM5 9aza-cytidine for 36 h, and
luciferase assays performed as described above. To block virus
replication, 0.3 mg/ml PAA was added to the media upon
infection.
Quantitative PCR
The vector DNA in uninfected and infected cells was
determined by quantitative real-time PCR. Cells (200,000) were
seeded into each well of a 12-well plate and infected with MCMV-
wt at an MOI of 0.5 or mock-treated. Total genomic DNA was
extracted from uninfected and infected cells 36 h post infection
(p.i.) using the DNeasy blood and tissue kit (Qiagen) according to
the manufacturer’s instructions. To quantify the ratio of pEpibo-
luc-ori per cell (before and after infection), two PCRs were
performed. One was specific for the pEpibo constructs, amplifying
the blasticidin resistance gene (bsr) using the primers bsr-for-
taqman 59-CCTCATTGAA AGAGCAACGGCTAC-39 and bsr-
rev-taqman 59-GCACCACGAGTTCTGCACAAGGT-39 and
the specific probe for bsr (59-FAM- CATCTCTGAAGACTA-
CAGCGTCGCCA-TAMRA-39). The second PCR was specific
for the cellular lamin B receptor (LBR) gene and used the primers
LBR-for (59-GGAAGTTTGTTGAGGGTGAAGTGGT-39) and
LBR-rev (59-CCAGTTCGGTGCCATCTTTGTATTT-39) and
a specific probe for LBR (59-FAM-CTGAGCCACG ACAA-
CAAATCCCAGCTCTAC-TAMRA-39). Vector DNA copy
number was calculated by comparing the amplification with
standard curves generated using the plasmids pEpibo-luc-ori or
p06IET-LBRfl. DNA amplification was performed using the
TaqMan 1000 RXN PCR core reagent kit (50 cycles of 95uC for
15 s and 60uC for 1 min) (Applied Biosystems).
Standard PCR
For the recombination assay, standard PCR was used to detect the
m74 gene with the primers m74-for 59-TCCGGACAACGTC-
TTTCCC-39 and m74-rev 59-CCTCAGTTCCACTTGCCAGC-39,
which amplify 316 bp inside the m74 gene. The primers M54-for 59-
ATCATCCGTTGCATCTCGTTG-3 and M54-rev 59-CGCC-
ATCTGTATCCGTCCAT-39 were used to detect the M54 gene.
Fluorescence and immunofluorescence microscopy
The immediate-early protein, ie1 (a marker of infection) was
detected using an indirect immunofluorescence assay. Cells were
fixed in 50% acetone-50% methanol and stained using the
monoclonal antibody, Croma 101 (kindly provided by Stipan
Jonjic, University of Rijeka, Croatia) followed by a Cy3-coupled
goat anti-mouse antibody (Dianova). Fluorescence and bright-field
imaging were observed on an Axiovert 200 M system (Zeiss).
Fluorescence in situ hybridization (FISH)
Metaphase spreads of proliferating NIH3T3:gfpscp-ori cells
were obtained after 2–3 h incubation with demecolcemid (0.1 mg/
ml, Sigma Aldrich) and resuspension in 0.91% (w/v) tri-sodium
citrate-dihydrate hypotonic solution. Cells were fixed in cold
Carnoy’s fixative (methanol:acetic acid; 3:1 v/v) and stored for 1
week before further processing. FISH was performed as previously
described with minor modifications [76]. Briefly, three different
probes were generated to detect the pEpibo-gfpscp-ori plasmid.
The first probe, detecting the bsr gene, was PCR-labeled with
biotin-ATP (NEB, USA) (using the primers bsr-for-FISH: 59-
ATGGCCAAGCCTTTGTCTCA-39 and bsr-rev-FISH 59-
AGATCGAGAAGCACCTGTCG-39) and the second probe,
detecting the gfpscp gene, was PCR-labeled with dig-UTP (Roche)
(using the primers P(SV40)-for-FISH: 59-TACCGAGCTCT-
TACGCGTGC-39 and pA(SV40)-rev-FISH 59-TAAGATA-
CATTGATGAGTTTGGA-39). The third probe, detecting the
oriLyt fragment, was generated by nick translation using DEAC-
UTP (Perkin Elmer, USA). Immunolabeling of the probes was
achieved by adding streptavidin-Cy3.5 (Rockland, USA) and an
anti-dig-fluorescein antibody (Roche Diagnostics, Germany). DNA
was counterstained with DAPI. Images of the FISH slides were
taken using an Axiovert 200 microscope (Zeiss, Germany) at 606
magnification.
Western Blotting
Western Blot analysis was performed as previously described
[41] using rat anti-HA (3F10, Roche), mouse anti-IE1/3
(CHROMA 101, kindly provided by Stipan Jonjic), mouse anti-
gp48 (CHROMA 221, kindly provided by Stipan Jonjic) and
rabbit anti-actin primary antibodies (20–33, Sigma). Horseradish
peroxidase-coupled anti-mouse, anti-rat, and anti-rabbit immu-
noglobulin-specific antibodies (Dianova) were used for immuno-
detection followed by the ECL-Plus (Amersham) system.
Statistical analysis
Statistical analysis was performed using GraphPad Prism4.
Two-way ANOVA was used to analyze differences unless
otherwise indicated. Asterisks denote statistically significant
differences (*P,0.05; **P,0.01; ***P,0.001).
Accession numbers
M50: GenBank ADD10432.1
m74: GenBank ADD10446.1
m48.2: GenBank ADD10430.1
MCMV Smith Strain: GenBank NC_004065
Supporting Information
Figure S1 Construction of the MCMV replicon vector. A)
The cloning of the highly repetitive oriLyt region was facilitated
via a ‘pick-up’- cloning strategy. By this way, long repetitive and
difficult to amplify regions can be cloned using a simple procedure.
To this end, a PCR fragment was generated containing a
kanamycin resistance gene (kanR) and the conditional bacterio-
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upstream of the oriLyt in the MCMV genome The PCR fragment
was recombined into the MCMV-BAC pSM3fr-FRT using
homologous recombination, thereby also destroying the transcrip-
tion initiation sites of the neighboring and overlapping M57 and
m58 genes. The genomic NheI site at 95767 and the introduction
of an additional NheI restriction facilitates the fragment containing
the oriLyt (blue) with the kan
R and oriR6K to be cut out and re-
circularized. The resulting plasmid pO6kan-MCMV-oriLyt was
selected for oriR6K maintenance by growth in E. coli PIR1 under
kanamycin selection. The oriLyt was now flanked by two MluI
sites, which can be used for further subcloning of the oriLyt into
the vector pEpibo resulting in the plasmid pEpibo-luc-ori (B) The
map of the pEpibo-luc-ori plasmid with S/MAR (scaffold/matrix
attachment region), bsr (Blasticidine resistance gene), P (Promoter),
pA (poly A). (C) Mechanism of replicon vector induction. In
uninfected cells (left) the reporter gene firefly luciferase (luc)o fa
replicon vector, which is an episomal plasmid harboring the oriLyt
of MCMV, is silenced. During infection with MCMV(right), the
virus provides all factors to replicate the oriLyt-containing
plasmid. This results in the replication and reactivation of the
episomal vector concomitantly with a strong induction of the silent
FL reporter gene expression (yellow).
(TIF)
Figure S2 Trans-activation of herpesviral promoters in
superinfection. To assay the induction capacity of different
promoters under infection, as well as their general expression
strength, bioluminescence analysis of transfected reporter plasmids
were performed. NIH3T3 cells were transfected with either
pEpibo-luc (with P(SV40)), or the respective constructs with the
immediate early promoter P(CMVie), the early promoter P(M143)
as well as the two late promoters P(M53) and P(M94). Respective
plasmids were generated by PCR amplification of the promoters
P(M143), P(M53) and P(M94) ( in general ,500 bp upstream of
the start ATG) inserting the restriction sites KpnI and HindIII, with
which they were further subcloned into the pEpibo-luc vector,
exchanging the P(SV40) promoter. Transfection was normalized
by the co-transfection of pTK-RL (Promega) encoding the renilla
luciferase. Cells were infected with MCMV at an MOI of 0.1 and
24 h (A) or 48 h p.i. (B) a bioluminescence assay was performed.
While the minimal P(SV40) is not influenced by MCMV infection,
all other promoters responded according to their typical
expression profiling in the viral context. (p.i.=post infection,
RLU=relative light units). Thus the P(SV40) promoter is well
suited to analyze the effect of the oriLyt sequence without taking
additional promoter induction into account.
(TIF)
Figure S3 Controls for 59Aza-cytidine and TSA. (A) A cell
line containing an integrated GFPSCP driven by a CMVie
promoter, namely NIH3T3:SB(GFPSCP) was used as positive
control for 59 aza-cytidine function. While the fluorescence of the
fusion protein was partially silenced, addition of 59Aza could
recover fluorescence dose dependently. (B) Removal of silencing in
the luc-ori cl.1 clone could be dose dependently recovered with
various concentrations of TSA or by infection with MCMV at an
MOI of 1. Bioluminescence assays were performed 36 h p.i. or
drug administration, respectively.
(TIF)
Figure S4 Limited co-operativity of TSA and infection
on FL induction. (A) Expression of MCMV proteins in TSA
treated cells. NIH3T3 were either untreated, treated with 330 nM
TSA (added by infection), or treated with 165 nM TSA (added 2 h
before infection, according to [26], infected with MCMV at an
MOI of 0.5. At 4, 12, 24, 48 h p.i. cells were harvested and
subjected to western blot analysis. Both TSA conditions had an
slight enhancing effect on immediate early gene expression at 4 h
p.i., major expression differences can be detected at late stages for
the proteins M50 and gp48.( B) To determine the effect of TSA on
virus replication MEF cells, 2 h pretreated with 330 nM TSA or
not, were infected with MCMV at an MOI of 0.1. TSA was
maintained in the medium throughout the assay. Supernatants
were collected over time and analyzed by standard plaque assay.
Treatment of the cells with TSA had a negative effect on virus
production by around 100 fold on day 5. (C) Luc-ori cl.1 cells were
treated with 0 nM, 83 nM, 165 nM or 330 nM Trichostatin A
and infected with MCMV at an MOI of 1 (hatched bars) or left
uninfected (plain bars). 36 h p.i. FL induction was measured via
bioluminescence assay. TSA treatment increased expression from
luc-ori cells in a dose dependent manner. Infection in TSA treated
cells did not reach luciferase reactivation of untreated cells. With
increasing concentration of TSA inhibition of MCMV could be
observed, thus only little synergistic effects on FL induction could
be obtained.
(TIF)
Figure S5 pEpibo-luc-ori is amplified upon MCMV
infection. NIH3T3 or luc-ori cl.1 - 4 were infected with MCMV
at an MOI of 1 (hatched bar) or left untreated (white bar,
mock).Quantitative realtime PCR was performed 36 h p.i. to
determine copy numbers of pEpibo-luc-ori vectors by a PCR
specific for the bsr coding sequence compared to a cellular single
copy gene lamin B receptor (lbr). (p.i., post infection; ***: p,0.001,
ns: p.0.05, Two-Way-ANOVA, depicted is mean+SD)
(TIF)
Figure S6 Non-invasive bioluminescence imaging of
VIOLA mice. A) Bioluminescence imaging of luciferase expres-
sion in living VIOLA mice after intravenous injection of
1610
6 PFU MCMV-wt (right mouse). Shown is one of three
mice in the experiment. As positive control 129X1/SvJ mice (129)
were infected with 1610
5 PFU MCMV-luc (left mouse) and to
assess the background bioluminescence 129 mice were infected
with 1610
6 PFU MCMV-wt (middle mouse). The pseudocolor
overlay represents the intensity of light emission, and thus the level
of FL expression. At various times after administration of MCMV,
the mice were imaged using a bioluminescence imaging system
(Xenogen) to detect FL expression. 10 min after intraperitoneal
injection of 2.5 mg luciferin ventral, lateral and dorsal images were
collected for 5 min with maximum sensitivity. The mice were
maintained under isoflurane anesthesia at 37uC. Strong signals of
the positive control could be detected in 129 mice. However no
signal from VIOLA mice was measurable. B) In order to exclude
that failure of bioluminescence induction is due to lacking infection
in the transgenic mice, viral titers in organ homogenates has been
determined. VIOLA mice (which were negative in the invasive
bioluminescence assay) were infected with 1610
6 PFU/ml
MCMV-wt and sacrificed at day 5. Organs were homogenized
and virus titers determined with standard plaque assay.
(TIF)
Figure S7 Southern Blot analysis of VIOLA lines.
Genomic DNA of 129X1/SvJ or VIOLA mouse tails was
extracted with the Qiagen Blood and Tissue Kit and 10 mg
digested with PstI. As control the vector pEpibo-luc-ori was
linearized with PstI and loaded at different amounts (100 ng,
10 ng, 1 ng, 100 pg, 10 pg, 1 pg). A 1.2 kb probe specifically
detecting the firefly luciferase gene was created with the PCR dig
probe synthesis kit (Roche). Southern Blot hybridization was
mainly performed as previously described [77]. Detection of
Replication Regulated Gene Expression
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detection kit. Asterisks mark specific bands probed with an anti-
luc-dig probe, indicating an integration of the pEpibo-luc-ori
constructs in the VIOLA lines. In case of an episomal persistence,
only one band on the size of the linearized control bands should
appear. Thus in the VIOLA lines the pEpibo-luc-ori plasmid is
least for the majority of the copies integrated into the mouse
chromosomes. Note, that the mouse lines A and B possess different
integration patterns.
(TIF)
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